Predictive models for starting antiseizure medication withdrawal following epilepsy surgery in adults.


Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
01 06 2023
Historique:
received: 22 07 2022
revised: 20 10 2022
accepted: 06 11 2022
medline: 2 6 2023
pubmed: 24 11 2022
entrez: 23 11 2022
Statut: ppublish

Résumé

More than half of adults with epilepsy undergoing resective epilepsy surgery achieve long-term seizure freedom and might consider withdrawing antiseizure medications. We aimed to identify predictors of seizure recurrence after starting postoperative antiseizure medication withdrawal and develop and validate predictive models. We performed an international multicentre observational cohort study in nine tertiary epilepsy referral centres. We included 850 adults who started antiseizure medication withdrawal following resective epilepsy surgery and were free of seizures other than focal non-motor aware seizures before starting antiseizure medication withdrawal. We developed a model predicting recurrent seizures, other than focal non-motor aware seizures, using Cox proportional hazards regression in a derivation cohort (n = 231). Independent predictors of seizure recurrence, other than focal non-motor aware seizures, following the start of antiseizure medication withdrawal were focal non-motor aware seizures after surgery and before withdrawal [adjusted hazard ratio (aHR) 5.5, 95% confidence interval (CI) 2.7-11.1], history of focal to bilateral tonic-clonic seizures before surgery (aHR 1.6, 95% CI 0.9-2.8), time from surgery to the start of antiseizure medication withdrawal (aHR 0.9, 95% CI 0.8-0.9) and number of antiseizure medications at time of surgery (aHR 1.2, 95% CI 0.9-1.6). Model discrimination showed a concordance statistic of 0.67 (95% CI 0.63-0.71) in the external validation cohorts (n = 500). A secondary model predicting recurrence of any seizures (including focal non-motor aware seizures) was developed and validated in a subgroup that did not have focal non-motor aware seizures before withdrawal (n = 639), showing a concordance statistic of 0.68 (95% CI 0.64-0.72). Calibration plots indicated high agreement of predicted and observed outcomes for both models. We show that simple algorithms, available as graphical nomograms and online tools (predictepilepsy.github.io), can provide probabilities of seizure outcomes after starting postoperative antiseizure medication withdrawal. These multicentre-validated models may assist clinicians when discussing antiseizure medication withdrawal after surgery with their patients.

Identifiants

pubmed: 36415957
pii: 6841346
doi: 10.1093/brain/awac437
doi:

Substances chimiques

Anticonvulsants 0

Types de publication

Observational Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2389-2398

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Carolina Ferreira-Atuesta (C)

Department of Clinical and Experimental Epilepsy (DCEE), NIHR University College London Hospitals Biomedical Research Centre, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.
Chalfont Centre for Epilepsy, Chalfont St Peter, Bucks SL9 0RJ, UK.
Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Jane de Tisi (J)

Department of Clinical and Experimental Epilepsy (DCEE), NIHR University College London Hospitals Biomedical Research Centre, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.
Chalfont Centre for Epilepsy, Chalfont St Peter, Bucks SL9 0RJ, UK.

Andrew W McEvoy (AW)

Department of Clinical and Experimental Epilepsy (DCEE), NIHR University College London Hospitals Biomedical Research Centre, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.
Chalfont Centre for Epilepsy, Chalfont St Peter, Bucks SL9 0RJ, UK.

Anna Miserocchi (A)

Department of Clinical and Experimental Epilepsy (DCEE), NIHR University College London Hospitals Biomedical Research Centre, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.
Chalfont Centre for Epilepsy, Chalfont St Peter, Bucks SL9 0RJ, UK.

Jean Khoury (J)

Cleveland Clinic Epilepsy Center, Cleveland, OH 44195, USA.

Ruta Yardi (R)

Cleveland Clinic Epilepsy Center, Cleveland, OH 44195, USA.

Deborah T Vegh (DT)

Cleveland Clinic Epilepsy Center, Cleveland, OH 44195, USA.

James Butler (J)

Constantiaberg Mediclinic Hospital, Division of Neurology, Neuroscience Institute, University of Cape Town, Cape Town 7800, South Africa.

Hamin J Lee (HJ)

Constantiaberg Mediclinic Hospital, Division of Neurology, Neuroscience Institute, University of Cape Town, Cape Town 7800, South Africa.

Victoria Deli-Peri (V)

Constantiaberg Mediclinic Hospital, Division of Neurology, Neuroscience Institute, University of Cape Town, Cape Town 7800, South Africa.

Yi Yao (Y)

Department of Epilepsy Surgery, Shenzhen Children's Hospital, Shenzhen, Guangdong 518048, China.
Department of Functional Neurosurgery, Xiamen Humanity Hospital, Xiamen, FuJian 361016, China.

Feng-Peng Wang (FP)

Department of Functional Neurosurgery, Xiamen Humanity Hospital, Xiamen, FuJian 361016, China.

Xiao-Bin Zhang (XB)

Department of Functional Neurosurgery, Xiamen Humanity Hospital, Xiamen, FuJian 361016, China.

Lubna Shakhatreh (L)

Department of Neuroscience, Central Clinical School, Alfred Health, Monash University, Level 6, Melbourne, Victoria 3000, Australia.
Departments of Medicine and Neurology, The Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria 3050, Australia.
Department of Neurology, Alfred Health, Melbourne, Victoria 3000, Australia.

Pakeeran Siriratnam (P)

Department of Neurology, Alfred Health, Melbourne, Victoria 3000, Australia.

Andrew Neal (A)

Department of Neuroscience, Central Clinical School, Alfred Health, Monash University, Level 6, Melbourne, Victoria 3000, Australia.
Departments of Medicine and Neurology, The Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria 3050, Australia.
Department of Neurology, Alfred Health, Melbourne, Victoria 3000, Australia.

Arjune Sen (A)

Oxford Epilepsy Research Group, NIHR Biomedical Research Centre, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 7BN, UK.
Department of Neurology, 3rd Floor, West Wing, John Radcliffe Hospital, Oxford OX3 9DU, UK.

Maggie Tristram (M)

Oxford Epilepsy Research Group, NIHR Biomedical Research Centre, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 7BN, UK.
Department of Neurology, 3rd Floor, West Wing, John Radcliffe Hospital, Oxford OX3 9DU, UK.

Elizabeth Varghese (E)

Department of Neurology, University Hospital of Wales, Cardiff CF14 4XW, UK.

Wendy Biney (W)

Department of Neurology, University Hospital of Wales, Cardiff CF14 4XW, UK.

William P Gray (WP)

The Wales Epilepsy Unit, Department of Neurology, University Hospital of Wales, Cardiff CF14 4XW, UK.

Ana Rita Peralta (AR)

Division of Psychological Medicine and Clinical Neurosciences Cardiff, Cardiff University, Cardiff CF14 4XW, UK.
Centro de Referência para Epilepsias Refratárias (member of EpiCare), Hospital de Santa Maria-Centro Hospitalar Universitário Lisboa Norte, Centro de Estudos Egas Moniz, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal.

Alexandre Rainha-Campos (A)

Division of Psychological Medicine and Clinical Neurosciences Cardiff, Cardiff University, Cardiff CF14 4XW, UK.
Centro de Referência para Epilepsias Refratárias (member of EpiCare), Hospital de Santa Maria-Centro Hospitalar Universitário Lisboa Norte, Centro de Estudos Egas Moniz, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal.

António J C Gonçalves-Ferreira (AJC)

Division of Psychological Medicine and Clinical Neurosciences Cardiff, Cardiff University, Cardiff CF14 4XW, UK.
Centro de Referência para Epilepsias Refratárias (member of EpiCare), Hospital de Santa Maria-Centro Hospitalar Universitário Lisboa Norte, Centro de Estudos Egas Moniz, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal.

José Pimentel (J)

Division of Psychological Medicine and Clinical Neurosciences Cardiff, Cardiff University, Cardiff CF14 4XW, UK.
Centro de Referência para Epilepsias Refratárias (member of EpiCare), Hospital de Santa Maria-Centro Hospitalar Universitário Lisboa Norte, Centro de Estudos Egas Moniz, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal.

Juan Fernando Arias (JF)

Epilepsy Center, Instituto Roosevelt, Bogotá 472, Colombia.

Samuel Terman (S)

University of Michigan Department of Neurology, Ann Arbor, MI 48109, USA.

Robert Terziev (R)

Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, CH-8006 Zurich, Switzerland.

Herm J Lamberink (HJ)

Department of Neurology, Haaglanden Medical Center, The Hague 2512 VA, The Netherlands.
Department of Child Neurology, University Medical Center Utrecht, Utrecht 3508 GA, The Netherlands.

Kees P J Braun (KPJ)

Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria 3084, Australia.

Willem M Otte (WM)

Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria 3084, Australia.

Fergus J Rugg-Gunn (FJ)

Department of Clinical and Experimental Epilepsy (DCEE), NIHR University College London Hospitals Biomedical Research Centre, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.
Chalfont Centre for Epilepsy, Chalfont St Peter, Bucks SL9 0RJ, UK.

Walter Gonzalez (W)

Epilepsy Center, Instituto Roosevelt, Bogotá 472, Colombia.

Carla Bentes (C)

Division of Psychological Medicine and Clinical Neurosciences Cardiff, Cardiff University, Cardiff CF14 4XW, UK.
Centro de Referência para Epilepsias Refratárias (member of EpiCare), Hospital de Santa Maria-Centro Hospitalar Universitário Lisboa Norte, Centro de Estudos Egas Moniz, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal.

Khalid Hamandi (K)

The Wales Epilepsy Unit, Department of Neurology, University Hospital of Wales, Cardiff CF14 4XW, UK.

Terence J O'Brien (TJ)

Department of Neuroscience, Central Clinical School, Alfred Health, Monash University, Level 6, Melbourne, Victoria 3000, Australia.
Departments of Medicine and Neurology, The Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria 3050, Australia.

Piero Perucca (P)

Department of Neuroscience, Central Clinical School, Alfred Health, Monash University, Level 6, Melbourne, Victoria 3000, Australia.
Departments of Medicine and Neurology, The Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria 3050, Australia.
Department of Neurology, Alfred Health, Melbourne, Victoria 3000, Australia.
Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria 3084, Australia.
Comprehensive Epilepsy Program, Austin Health, Heidelberg, Victoria 3084, Australia.

Chen Yao (C)

Department of Neurosurgery, the First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, Guangdong 518037, China.
Shenzhen Epilepsy Center (Shenzhen Children's Hospital and Shenzhen Second People's Hospital), Shenzhen 518037, China.

Richard J Burman (RJ)

Constantiaberg Mediclinic Hospital, Division of Neurology, Neuroscience Institute, University of Cape Town, Cape Town 7800, South Africa.
Oxford Epilepsy Research Group, NIHR Biomedical Research Centre, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 7BN, UK.
Department of Neurology, 3rd Floor, West Wing, John Radcliffe Hospital, Oxford OX3 9DU, UK.

Lara Jehi (L)

Cleveland Clinic Epilepsy Center, Cleveland, OH 44195, USA.

John S Duncan (JS)

Department of Clinical and Experimental Epilepsy (DCEE), NIHR University College London Hospitals Biomedical Research Centre, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.
Chalfont Centre for Epilepsy, Chalfont St Peter, Bucks SL9 0RJ, UK.

Josemir W Sander (JW)

Department of Clinical and Experimental Epilepsy (DCEE), NIHR University College London Hospitals Biomedical Research Centre, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.
Chalfont Centre for Epilepsy, Chalfont St Peter, Bucks SL9 0RJ, UK.
Department of Neurology, West China Hospital, Sichuan University, Chengdu 610041, China.
Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede 2103SW, The Netherlands.

Matthias Koepp (M)

Department of Clinical and Experimental Epilepsy (DCEE), NIHR University College London Hospitals Biomedical Research Centre, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.
Chalfont Centre for Epilepsy, Chalfont St Peter, Bucks SL9 0RJ, UK.

Marian Galovic (M)

Department of Clinical and Experimental Epilepsy (DCEE), NIHR University College London Hospitals Biomedical Research Centre, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.
Chalfont Centre for Epilepsy, Chalfont St Peter, Bucks SL9 0RJ, UK.
Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, CH-8006 Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH